Bioidentical Progesterone (Topical).

Vitex acts on pituitary dopamine D2 receptors and lowers prolactin release, part of what sets luteal-phase progesterone output. It works on the signal upstream while a cream delivers the hormone itself.

Progesterone and DHEA come off pregnenolone down the delta-4 and delta-5 branches respectively. Supplying one does not raise the other, so formulas wanting both carry both.

Wild yam creams are often assumed to deliver progesterone because diosgenin is its laboratory starting material, but no human enzyme performs that conversion. Only a cream with progesterone added delivers progesterone.

St. John's Wort induces CYP3A4, which metabolises progesterone once it reaches circulation. Exposure from the same applied amount falls.

Pyridoxal-5-phosphate is the cofactor for dopamine synthesis, and dopamine tone holds pituitary prolactin release in check. That is the same upstream lever vitex acts on.

Steroids leave the body as glucuronide conjugates, and gut beta-glucuronidase can cleave them back to free hormone. Calcium D-glucarate inhibits that enzyme, changing how much returns to circulation.

Progesterone is a neutral lipophilic steroid with poor water solubility, so the vehicle decides how much reaches the stratum corneum. Medium-chain triglycerides dissolve it and keep it dispersed in the oil phase of a cream. This is a formulation relationship rather than a physiological one, and the delivered amount still depends on the finished base and the applied area.

Phosphatidylcholine forms bilayer vesicles that carry lipophilic molecules into the upper skin layers and fluidise stratum corneum lipids. Topical progesterone preparations use it for that reason. The effect is on delivery of the applied material, not on hormone activity itself.

Cream bases carrying a steroid are usually oil-in-water emulsions whose lipid phase oxidises over shelf life. Tocopherol is added as a lipid-phase antioxidant to slow that. It supports the stability of the product, and no claim about hormone response follows from it.

The progesterone receptor is a nuclear receptor whose DNA-binding domain is built around two zinc-coordinating structural motifs, so zinc is structurally required for the receptor to bind its response element. That is textbook receptor biochemistry and is not a dose-response argument. Nothing here says extra zinc increases receptor signalling.

Magnesium is a required cofactor for catechol-O-methyltransferase and for the ATP-dependent steps that supply sulfation and methylation reactions used in steroid hormone handling. Adequate magnesium therefore supports normal hormone metabolism as a general cofactor role. It is a supporting relationship, not a demonstrated additive effect with applied progesterone.

DIM shifts hepatic CYP1A-mediated hydroxylation of oestrogens, which is the same phase I machinery that processes other steroid substrates. Formulators pair the two when the intention is to support normal hormone metabolism rather than to add hormone. Human data on the combination is thin, so this sits on pathway logic rather than a combination trial.

Silymarin components inhibit UDP-glucuronosyltransferase and some CYP isoforms in laboratory systems, and progesterone is cleared largely by CYP3A4 and glucuronidation. The direction of any real-world change is uncertain and has not been measured for a topical steroid. Flagged because it is a plausible metabolic interaction rather than a benefit.

Progesterone is reduced in the body to allopregnanolone, a positive allosteric modulator at GABA-A receptors, and valerian constituents act at the same receptor complex. Pairing them can be additive for calm and normal sleep onset. Anyone stacking sedating ingredients should account for that additivity.

Allopregnanolone, the main neuroactive metabolite of progesterone, potentiates GABA-A currents. Products aimed at evening calm sometimes pair the two on that shared target. Oral GABA crosses into the brain poorly, which limits how much of this is realised in practice.

Passionflower flavonoids show GABA-A activity in preclinical work, the same receptor family the progesterone metabolite modulates. The pairing appears in evening formulas for normal sleep onset. Evidence for the combination in people has not been reported.

Melatonin sets circadian timing while progesterone and its metabolites influence sleep architecture through GABA-A. Both are used in the evening, so their effects on sleep continuity can overlap. No combination measurement in people is available, and this is pathway reasoning only.

Boron supplementation has been reported to shift circulating steroid hormone concentrations in small human studies. Those are blood markers rather than clinical outcomes, and the direction varies with baseline status. It is worth naming as a plausible modulator of hormone measurements, not as an effect on applied progesterone.

Vitamin D3 is a secosteroid built from a cholesterol precursor, the same sterol pool that feeds pregnenolone and then progesterone. That shared origin is chemistry, not a demonstrated interaction. Any co-formulation rationale should be stated as pathway overlap only.

Squalane is a saturated hydrocarbon emollient that dissolves lipophilic actives and is stable against oxidation. In a topical steroid base it functions as part of the oil phase and as a skin-conditioning agent. Its role is delivery and feel, and it carries no hormonal activity of its own.